Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
203 search results
That which we call rosaimab by any other name would find regulatory approval and commercial success. Or would it?
Are all antibiotics doomed to eventual impotence? New work from Oxford could change the game by defeating resistance itself.
Sitting Down With Dolores Schendel, Chief Executive Officer and Chief Scientific Officer at Medigene.
Thorben Seeger wants to democratize the data held by the world’s leading genomic institutions. But what exactly does he mean by “democratize”?
The Russian invasion of Ukraine will disrupt and displace a great deal of work in drug discovery. Here’s why.
Enter the world of immersive therapeutics – where VR is being explored as an alternative to traditional medicines for pain.
Welcome to Part II of our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.
Work by an international team in Japan has found a new and effective way to attack cancer inside the body.
As the fires of the American opioid crisis continue to burn, can new painkillers step in?
Read our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
Celebrating the Pharma Industry’s Most Inspirational People and Companies
An Ode to Flexible Cleanroom Furniture